The comparative immunotherapy program actively fosters and supports interdisciplinary collaborations and partnerships across departments and schools within the University of Pennsylvania and beyond, that engage in comparative translational research. The program leverages the depth and breadth of expertise of faculty, particularly in the fields of immunobiology and immunotherapy, to expedite the translation of safe and effective cutting edge treatments for both companion animals and their humans. Programs within the program include organ transplantation, autoimmunity and inflammation, immuno-oncology and infectious disease.
Program Leaders
 |
Nicola Mason, BVetMed, PhD, MRCVS
|
- Director, Comparative Immunotherapy Program
James & Gilmore Professor of Medicine
|
 |
Antonia Rotolo, MD, PhD
|
- Director, Effector Cell Therapies
|
 |
Allison Ardon
|
- Assistant to the Director
aardon@upenn.edu
|
Affiliated Faculty
Jorge Alvarez, BSc, PhD
Assistant Professor, Pathobiology
Department of Pathobiology
Lillian Aronson, BS, VMD
Professor, Surgery
Department of Clinical Studies
Molly Church, MS, VMD, PhD
Assistant Professor, Pathobiology
Department of Pathobiology
Stephen Cole, MS, VMD
Assistant Professor, Clinical Microbiology
Department of Pathology
Raimon Duran-Struuck, B.S., DVM, PhD
Associate Professor, Pathobiology
Department of Pathobiology
Michael J. Hogan, PhD
Assistant Professor, Pathobiology
Department of Pathobiology
Emmelyn Hsieh
Assistant Professor, Medicine
Department of Clinical Studies
Elizabeth Lennon, DVM, PhD
Pamela Cole Assistant Professor, Internal Medicine
Department of Clinical Studies
Nicola Mason, BVetMed, PhD
Professor, Medicine and Pathobiology
Department of Pathobiology
Erica Reineke
Associate Professor, Emergency & Critical Care
Department of Clinical Studies
Antonia Rotolo, MD, PhD
Research Assistant Professor, Immuno-Biology
Department of Pathobiology
Donald L. Siegel, PhD, MD
Professor, Pathology and Laboratory Medicine
Department of Pathology and Laboratory Medicine
Kristy Weber, MD
Abramson Family Professor in Sarcoma Care Excellence
Department of Orthopaedic Surgery
In the News
Study shows promise for iNKT cell platform to treat cancer
Researchers from the School of Veterinary Medicine and Perelman School of Medicine have shown that invariant natural killer T cells from a healthy donor can persist in MHC-mismatched canines, demonstrating a reliable platform to inform human clinical trials.
